⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ALNY News
Alnylam Pharmaceuticals, Inc.
New Post Hoc Analysis from the HELIOS-B Phase 3 Study Shows Vutrisiran Improved Measures of Heart Structure and Function in Patients with ATTR-CM
businesswire.com
ALNY
Alnylam to Webcast Presentations at Upcoming November Investor Conferences
businesswire.com
ALNY
Alnylam Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Period Progress
businesswire.com
ALNY
ALNY
Alnylam Pharmaceuticals joins Alliance for Genomic Discovery, expanding diverse clinical genomic dataset to drive precision medicine
prnewswire.com
ILMN
ALNY
Alnylam Announces Proposed Offering of $500 Million Convertible Senior Notes
businesswire.com
ALNY
ALNY